Clinical trials
Technology clinical trials
Below are recruiting technology clinical trials, each written for real people, not researchers. We’re tracking 1,080 recruiting studies, each written for real people, not researchers, below.
Recruiting studies
- NCT07650682Recruiting
Blood Sugar and Hormone Patterns in Type 2 Diabetes
This study uses math models to understand how your blood sugar and hormones respond to food and insulin. You'll eat study foods and provide blood samples so researchers can better predict how your body handles diabetes.
Chicago, IllinoisAges 18–65 - NCT07651826Recruiting
Study of Immiseal Dural Sealant in Brain and Spine Surgery
This study tracks how well Immiseal, a special sealing material, works when applied during brain or spine surgery to prevent fluid leaks from the protective membrane around the brain and spinal cord. You'll be followed after surgery to see how well the sealant performs and if you have any side effects.
RigaAges 18–75 - NCT07647315Recruiting
Wireless Brain Implant for Speech Recovery
This trial tests a small wireless device implanted in the brain to help people with severe speech difficulties—caused by stroke, ALS, or brain injury—communicate again. The device reads brain signals and converts them to Mandarin Chinese speech.
Shanghai, Shanghai MunicipalityAges 18–80 - NCT07653477RecruitingPhase 3
New diabetes drug for type 2 diabetes not well controlled with metformin
This trial tests an investigational drug called UBT251 for people with type 2 diabetes whose blood sugar is not well controlled despite taking metformin, either alone or with another diabetes medicine. The goal is to see if it can lower blood sugar levels more than a placebo.
ShanghaiAges 18–75 - NCT07652437Recruiting
Wearable device study for knee osteoarthritis walking
This study tests whether a wearable device can help people with knee osteoarthritis walk more easily and for longer periods. If you have knee pain or stiffness on most days and find walking difficult, this might help you improve your mobility.
Cambridge, MassachusettsAges 21–100 - NCT07648160Recruiting
Advanced Imaging Technology for Radiation Cancer Treatment
This study tests a new imaging camera that uses special dye to help doctors see tumors better during radiation therapy. It may help doctors target cancer more precisely while protecting healthy tissue.
Toronto, OntarioAges 18 years+ - NCT06141460RecruitingPhase 1/Phase 2
Gene therapy trial for wet age-related macular degeneration
This trial tests a new gene therapy called RRG001 for people with the 'wet' form of age-related macular degeneration. It aims to treat leaky blood vessels in the eye that can cause vision loss, possibly reducing the need for frequent eye injections.
Tianjin, Tianjin MunicipalityAges 50 years+ - NCT06296706RecruitingPhase 3
Study of a new docetaxel for advanced stomach cancer
This trial is testing a new form of the chemotherapy drug docetaxel (called albumin-bound docetaxel) for people with advanced stomach or gastroesophageal junction cancer that has worsened after initial treatment. It aims to see if this version of the drug works better or has fewer side effects.
Shijiazhuang, HebeiAges 18–75 - NCT07639450RecruitingPhase 1/Phase 2
N-3C01 Cancer Treatment Study for Advanced Solid Tumors
This trial tests a new drug called N-3C01, alone or combined with immune-boosting medications, in patients whose advanced cancer has stopped responding to standard treatments. The goal is to see if this approach can slow or shrink tumors that have become resistant to other therapies.
Saint Leonards, New South WalesAges 18–75 - NCT07643623RecruitingPhase 2/Phase 3
Immunotherapy for operable stomach cancer before and after surgery
This trial tests a combination of immunotherapy drugs (sintilimab, chemotherapy, and sometimes ipilimumab) given before surgery to shrink stomach or esophageal junction tumors, then continued after surgery. The goal is to improve survival in patients with resectable (removable) gastric or gastroesophageal junction cancer.
Guangzhou, GuangdongAges 18 years+ - NCT04876950Recruiting
Remote check-ins after surgery using a tablet
This trial tests a virtual follow-up program after surgery, using remote automated monitoring and tablet-based check-ins. It may help with safer recovery by letting the care team follow how you’re doing after you leave the hospital.
Hamilton, OntarioAges 40 years+ - NCT06557369Recruiting
New light therapy for intermediate age-related macular degeneration
This trial tests a new light-based treatment for intermediate age-related macular degeneration (AMD), a common eye condition that can lead to vision loss. The goal is to see if it is safe and helps slow down the disease.
BergamoAges 50 years+ - NCT07642622Recruiting
Physical Activity Tracking With Wearable Technology for Spine Arthritis
This study tests whether wearing a Fitbit activity tracker and using a Google Health app can help people with axial spondyloarthritis (a type of spine arthritis) become more physically active. The goal is to see if this technology-based approach motivates people to exercise more, which may help reduce pain and improve their condition.
Seattle, WashingtonAges 18 years+ - NCT07642401Enrolling by invitation
Building models to understand esophageal cancer
This research study uses medical records and imaging from patients with various esophageal conditions—from inflammation to cancer—to develop better diagnostic and prediction tools. Researchers want to understand what changes in the esophagus lead to cancer and how to catch it earlier.
Anyang, HenanAges 18–90 - NCT07645729Recruiting
Testing a Powered Ankle Prosthesis with Neural Control
This study tests a new powered ankle prosthesis (an artificial foot with a motor) that you control using signals from your nerves and receive feedback through gentle stimulation on your skin. The goal is to see if it helps you walk more naturally and perform daily activities with better balance and control.
Cambridge, MassachusettsAges 18–70 - NCT03944876RecruitingPhase 3
Botulinum toxin to block a facial nerve for chronic cluster headaches
This trial tests whether injections of botulinum toxin type A can reduce frequent, severe cluster headache attacks by targeting a facial nerve area. It’s for people whose cluster headaches have not responded well—or have caused side effects—to standard preventive treatments.
HamburgAges 18–85 - NCT07630233RecruitingPhase 1
Safety and effects of UBT38006 injection in healthy men
This early-stage study tests a new injectable medication (UBT38006) in healthy adult men to understand how safe it is and how the body processes it. Researchers want to make sure the injection doesn't cause serious side effects and works as expected.
Hefei, AnhuiAges 18–45 - NCT07631793RecruitingPhase 1
Experimental vaccine for advanced solid tumors
This trial tests an experimental vaccine called YKYY031 for people with advanced solid tumors that have stopped responding to standard treatments. The vaccine aims to help your immune system fight cancer cells that carry specific markers. It may be an option if you have certain genetic markers and tumor proteins.
Beijing, Beijing MunicipalityAges 18–75 - NCT07631442Enrolling by invitation
Digital Health Monitoring for Primary Biliary Cholangitis
This study uses a smartphone app or digital platform to track how you're feeling day-to-day if you have primary biliary cholangitis (PBC), a liver condition where your immune system damages bile ducts. Researchers want to see if this digital monitoring helps them better understand and manage PBC symptoms.
Redwood City, CaliforniaAges 18 years+ - NCT06689865Recruiting
Hearing aid study for adults with mild to moderate hearing loss
This study tests four different ways to provide over-the-counter hearing aids to adults with mild-to-moderate hearing loss. It aims to find the best approach to help people hear better and improve their quality of life.
Aurora, ColoradoAges 40 years+ - NCT06693973RecruitingEarly Phase 1
AcNK-Sup003 cell therapy for relapsed B-cell lymphoma
This early-phase trial tests a new immune cell treatment called AcNK-Sup003 for people with B-cell non-Hodgkin's lymphoma that has come back or not responded to prior therapy. The goal is to see if it is safe and effective.
Wuhan, HubeiAges 18 years+ - NCT07624500Recruiting
How Different Foods Affect Your Metabolism and Blood Sugar
This study tests how specific foods impact your body's ability to manage blood sugar and fat levels. You'll eat meals provided by the research team for about 12 weeks to help researchers understand which foods work best for people with high triglycerides (a type of blood fat) and insulin resistance (difficulty managing blood sugar).
Chicago, IllinoisAges 40–70 - NCT07624929Enrolling by invitation
Virtual Reality to Reduce Anxiety During Varicose Vein Treatment
This study tests whether wearing a virtual reality headset during varicose vein treatment (a minimally invasive laser procedure on your legs) can help reduce anxiety and pain. You'd use VR while the doctor treats the problematic veins under local anesthesia.
BydgoszczAges 18 years+ - NCT07621679Recruiting
Walking Program to Prevent Falls and Fractures in Older Adults
This study tests whether a specialized walking and balance program helps people aged 70+ with weak bones reduce their risk of falls and fractures. The program is designed to improve strength, balance, and confidence in daily movement.
Montreal, QuebecAges 70 years+
Hear when a new Technology trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.
Common questions
- Are there clinical trials for technology?
- Yes. Clin2 currently lists 1,080 recruiting technology studies from the U.S. registry, each rewritten for real people, not researchers, so you can see what it’s testing and who it’s for.
- How do I know if I qualify for a technology trial?
- Each study lists its eligibility criteria — rules about age, diagnosis, and prior treatments. On every Clin2 trial page we explain these in words written for real people and offer a short, optional pre-screen for a fit read. The study team makes the final decision.
- Does it cost anything to join a technology trial?
- Using Clin2 is always free. Many trials cover the cost of the study treatment and related visits; some reimburse travel. The study team explains exactly what’s covered before you decide.
Related conditions
Clin2 helps you find and understand clinical trials and does not provide medical advice. Study data comes from ClinicalTrials.gov. Talk with your doctor about whether a specific trial is right for you.